Respiratory disease affects one in five people in England and is the third largest cause of death, with around 68,000 people dying every year. (Source: Public Health England) 

Incidence and mortality rates are worse in deprived areas and for disadvantaged groups. From 2017 to 2019 in England, early mortality from respiratory disease was 2.9 times higher in the most deprived areas compared to the highest socioeconomic areas, contributing no small part to the widening life expectancy gap (Source: The Marmot Review). 

We’re supporting the ambition outlined in the NHS Long Term Plan to detect and diagnose respiratory problems sooner while increasing equal access to testing. Respiratory rehabilitation, medication and digital tools will play a key part here, ensuring an improved quality of life and enabling people to self-manage conditions. 

Our initiatives aim to enhance severe asthma management and improve asthma care pathways for all patients. We’re also accelerating access to a number of innovations along the severe asthma pathway that will support faster diagnosis and optimised treatments.

Previous programmes

Bettering access to FeNO testing in primary care

Together, we helped transform asthma care by improving access to innovative diagnostics and management that enabled accurate and almost-instant diagnoses.

Doctor in light blue shirt using stethoscope to take heart beat of young boy, who is standing and wearing a blue checked shirt

Improving access to innovative asthma biologics

Together, we helped make innovative treatments available for patients with severe asthma, reducing the number of life-threatening asthma attacks and the long-term side effects of other treatments.

Female doctor in green overalls talking to lady in brown cardigan